

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in visual perception (GO:0050908) | 6.65941098 |
| 2 | detection of light stimulus involved in sensory perception (GO:0050962) | 6.65941098 |
| 3 | retinal cone cell development (GO:0046549) | 6.42453729 |
| 4 | rhodopsin mediated signaling pathway (GO:0016056) | 6.27622388 |
| 5 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.21133113 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 5.28874835 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.21042408 |
| 8 | retinal rod cell development (GO:0046548) | 5.12795551 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.00368987 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.00368987 |
| 11 | response to peptidoglycan (GO:0032494) | 4.80437759 |
| 12 | photoreceptor cell development (GO:0042461) | 4.70753422 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.66683122 |
| 14 | photoreceptor cell maintenance (GO:0045494) | 4.66228676 |
| 15 | eye photoreceptor cell development (GO:0042462) | 4.63959756 |
| 16 | cellular extravasation (GO:0045123) | 4.54080616 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.36376279 |
| 18 | detection of other organism (GO:0098543) | 4.33461676 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.27904272 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.27252407 |
| 21 | detection of visible light (GO:0009584) | 4.16349952 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12273665 |
| 23 | phototransduction, visible light (GO:0007603) | 4.04576591 |
| 24 | protein-chromophore linkage (GO:0018298) | 4.03655564 |
| 25 | detection of light stimulus (GO:0009583) | 4.00473822 |
| 26 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.97997688 |
| 27 | phototransduction (GO:0007602) | 3.94118202 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.91963398 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91209656 |
| 30 | detection of bacterium (GO:0016045) | 3.85347298 |
| 31 | detection of biotic stimulus (GO:0009595) | 3.81009104 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.75430510 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.72882055 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71994821 |
| 35 | respiratory burst (GO:0045730) | 3.67999207 |
| 36 | visual perception (GO:0007601) | 3.66781189 |
| 37 | regulation of guanylate cyclase activity (GO:0031282) | 3.64226698 |
| 38 | sensory perception of light stimulus (GO:0050953) | 3.64034169 |
| 39 | neutrophil activation (GO:0042119) | 3.58084427 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.54755096 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50745941 |
| 42 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.49954182 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.48604259 |
| 44 | macrophage activation (GO:0042116) | 3.48051815 |
| 45 | granulocyte activation (GO:0036230) | 3.46571553 |
| 46 | germinal center formation (GO:0002467) | 3.46433165 |
| 47 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41393556 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 3.38034586 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34675534 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.25343594 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25220344 |
| 52 | microglial cell activation (GO:0001774) | 3.25132980 |
| 53 | cell adhesion mediated by integrin (GO:0033627) | 3.24000256 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.21740717 |
| 55 | leukocyte aggregation (GO:0070486) | 3.21075298 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.20736173 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19904422 |
| 58 | sodium ion export (GO:0071436) | 3.19753210 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19098492 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19098492 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 3.19098492 |
| 62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19098492 |
| 63 | modulation by symbiont of host defense response (GO:0052031) | 3.19098492 |
| 64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19098492 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.18702657 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17622057 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16505111 |
| 68 | response to interleukin-15 (GO:0070672) | 3.16434984 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.15808387 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13966816 |
| 71 | neutrophil mediated immunity (GO:0002446) | 3.12509013 |
| 72 | eye photoreceptor cell differentiation (GO:0001754) | 3.11541288 |
| 73 | photoreceptor cell differentiation (GO:0046530) | 3.11541288 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02224757 |
| 75 | response to host immune response (GO:0052572) | 3.02224757 |
| 76 | protein localization to endosome (GO:0036010) | 3.00167332 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 3.00084463 |
| 78 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.98534274 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98104429 |
| 80 | immunoglobulin mediated immune response (GO:0016064) | 2.96531936 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90304165 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90168429 |
| 83 | response to host (GO:0075136) | 2.88263560 |
| 84 | response to host defenses (GO:0052200) | 2.88263560 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88263560 |
| 86 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.87479606 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85711436 |
| 88 | regulation of tolerance induction (GO:0002643) | 2.85160767 |
| 89 | regulation of regulated secretory pathway (GO:1903305) | 2.81720502 |
| 90 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.81587036 |
| 91 | regulation of mast cell activation (GO:0033003) | 2.81031259 |
| 92 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79255420 |
| 93 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79088224 |
| 94 | detection of external stimulus (GO:0009581) | 2.76796158 |
| 95 | regulation of cGMP metabolic process (GO:0030823) | 2.76766774 |
| 96 | neutrophil chemotaxis (GO:0030593) | 2.76234097 |
| 97 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.74829063 |
| 98 | T-helper 1 type immune response (GO:0042088) | 2.73578108 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 2.73385499 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72915312 |
| 101 | regulation of macrophage cytokine production (GO:0010935) | 2.70508276 |
| 102 | regulation of B cell differentiation (GO:0045577) | 2.69455998 |
| 103 | neutrophil migration (GO:1990266) | 2.68790809 |
| 104 | detection of abiotic stimulus (GO:0009582) | 2.68622887 |
| 105 | negative regulation of type 2 immune response (GO:0002829) | 2.66968166 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66471016 |
| 107 | positive regulation of mast cell degranulation (GO:0043306) | 2.66471016 |
| 108 | import into cell (GO:0098657) | 2.65185631 |
| 109 | response to laminar fluid shear stress (GO:0034616) | 2.65098228 |
| 110 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62618535 |
| 111 | regulation of T cell tolerance induction (GO:0002664) | 2.62198624 |
| 112 | positive regulation of interferon-alpha production (GO:0032727) | 2.61822138 |
| 113 | dendritic cell chemotaxis (GO:0002407) | 2.61659520 |
| 114 | embryonic process involved in female pregnancy (GO:0060136) | 2.61544041 |
| 115 | regulation of cGMP biosynthetic process (GO:0030826) | 2.61033937 |
| 116 | potassium ion homeostasis (GO:0055075) | 2.60836943 |
| 117 | cellular response to light stimulus (GO:0071482) | 2.60350170 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 2.59291886 |
| 119 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.59116958 |
| 120 | leukocyte degranulation (GO:0043299) | 2.57965018 |
| 121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57541542 |
| 122 | dendritic cell migration (GO:0036336) | 2.57315734 |
| 123 | adhesion of symbiont to host (GO:0044406) | 2.57225894 |
| 124 | positive regulation of regulated secretory pathway (GO:1903307) | 2.57194886 |
| 125 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.56918144 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.55856976 |
| 127 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.55856976 |
| 128 | tolerance induction (GO:0002507) | 2.55180125 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.55150237 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.55150237 |
| 131 | response to lipoprotein particle (GO:0055094) | 2.55076455 |
| 132 | myeloid leukocyte mediated immunity (GO:0002444) | 2.54985822 |
| 133 | response to type I interferon (GO:0034340) | 2.54362666 |
| 134 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.53824111 |
| 135 | retina development in camera-type eye (GO:0060041) | 2.49006970 |
| 136 | macroautophagy (GO:0016236) | 2.47932675 |
| 137 | positive regulation of cGMP metabolic process (GO:0030825) | 2.45015415 |
| 138 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.43930126 |
| 139 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.43756557 |
| 140 | apoptotic cell clearance (GO:0043277) | 2.43126497 |
| 141 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.41549813 |
| 142 | lymphangiogenesis (GO:0001946) | 2.39924542 |
| 143 | iron ion import (GO:0097286) | 2.39383126 |
| 144 | virion attachment to host cell (GO:0019062) | 2.39063879 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.39063879 |
| 146 | positive regulation of p38MAPK cascade (GO:1900745) | 2.38954047 |
| 147 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.36651431 |
| 148 | wound healing, spreading of epidermal cells (GO:0035313) | 2.35729450 |
| 149 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33213719 |
| 150 | potassium ion import (GO:0010107) | 2.30216584 |
| 151 | hemidesmosome assembly (GO:0031581) | 2.29284136 |
| 152 | lipoprotein transport (GO:0042953) | 2.28337307 |
| 153 | negative regulation of fatty acid transport (GO:2000192) | 2.28210755 |
| 154 | cellular response to vitamin (GO:0071295) | 2.28041116 |
| 155 | semaphorin-plexin signaling pathway (GO:0071526) | 2.26667193 |
| 156 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.25288273 |
| 157 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.21615991 |
| 158 | relaxation of smooth muscle (GO:0044557) | 2.20494571 |
| 159 | renal filtration (GO:0097205) | 2.20480829 |
| 160 | GMP metabolic process (GO:0046037) | 2.18299918 |
| 161 | macrophage activation involved in immune response (GO:0002281) | 2.16580348 |
| 162 | lymph vessel development (GO:0001945) | 2.16529552 |
| 163 | substrate-dependent cell migration (GO:0006929) | 2.15834634 |
| 164 | cellular response to interferon-alpha (GO:0035457) | 2.13020797 |
| 165 | regulation of cholesterol storage (GO:0010885) | 2.12688518 |
| 166 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.12055526 |
| 167 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.11629616 |
| 168 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.11622446 |
| 169 | apical protein localization (GO:0045176) | 2.11574370 |
| 170 | mannose metabolic process (GO:0006013) | 2.09690125 |
| 171 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.08558337 |
| 172 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.06966255 |
| 173 | regulation of p38MAPK cascade (GO:1900744) | 2.05555311 |
| 174 | axon extension involved in axon guidance (GO:0048846) | 2.04454930 |
| 175 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.04454930 |
| 176 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.04074040 |
| 177 | wound healing, spreading of cells (GO:0044319) | 2.04012814 |
| 178 | positive regulation of calcium ion import (GO:0090280) | 2.00289247 |
| 179 | surfactant homeostasis (GO:0043129) | 2.00188722 |
| 180 | phospholipid translocation (GO:0045332) | 1.99806762 |
| 181 | lipid translocation (GO:0034204) | 1.99806762 |
| 182 | response to fluid shear stress (GO:0034405) | 1.98109585 |
| 183 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 1.97329034 |
| 184 | positive regulation of hormone biosynthetic process (GO:0046886) | 1.96743916 |
| 185 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 1.95951185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.28429305 |
| 2 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19270308 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.10423841 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.77924401 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72571115 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.71900348 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42931080 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41294865 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33756582 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28363602 |
| 11 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.27332729 |
| 12 | * MYC_22102868_ChIP-Seq_BL_Human | 2.25608904 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20831424 |
| 14 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.10911791 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07754580 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07291629 |
| 17 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06918021 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.05181074 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97112134 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95378531 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93958159 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88468014 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86278069 |
| 24 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85828099 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85538651 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85424739 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83787033 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83632340 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.82724802 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81457382 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.79254297 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78026794 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76756523 |
| 34 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.74458600 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.73038118 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72740766 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70616709 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.70192531 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.64701640 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61902461 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.60608901 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58731449 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58558658 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.54202513 |
| 45 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.53170532 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49253527 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49197845 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49005921 |
| 49 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48508625 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48181419 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46733704 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46225354 |
| 53 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43851168 |
| 54 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.43231534 |
| 55 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.41184762 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40714762 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40510344 |
| 58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39828056 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39485057 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39458820 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36621407 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35185247 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34750346 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34750346 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34566013 |
| 66 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.34355204 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33791737 |
| 68 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33081460 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.32249085 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32132105 |
| 71 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30676382 |
| 72 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29842990 |
| 73 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27246245 |
| 74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27011981 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26466300 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.26210177 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25938353 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25717853 |
| 79 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25674373 |
| 80 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25179406 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25174792 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25107626 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24570405 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22913479 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22720845 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22647532 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20945955 |
| 88 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20519155 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20418437 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20240718 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18505294 |
| 92 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17901271 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16163477 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15696622 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14956044 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14179216 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13975073 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13687312 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13141977 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12976786 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12833155 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12240561 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11705426 |
| 104 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10845835 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10174170 |
| 106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09297067 |
| 107 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09297067 |
| 108 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08586187 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07924925 |
| 110 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.07896913 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07868792 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07253612 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06951459 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06236040 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05077268 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04759424 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04138265 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03202490 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02682985 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02297327 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01804747 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00782766 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00685813 |
| 124 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99838289 |
| 125 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99095842 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98893064 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98574324 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97949043 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97497924 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97281418 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97072655 |
| 132 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96806698 |
| 133 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96359788 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95592994 |
| 135 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95323815 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94816735 |
| 137 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94815374 |
| 138 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94636186 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93798811 |
| 140 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93007868 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91359611 |
| 142 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91237844 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91031895 |
| 144 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90418679 |
| 145 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90129442 |
| 146 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89938700 |
| 147 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89559802 |
| 148 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89021415 |
| 149 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.88837225 |
| 150 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.88807203 |
| 151 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88667768 |
| 152 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88667768 |
| 153 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88384410 |
| 154 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88110320 |
| 155 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87578082 |
| 156 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86680184 |
| 157 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86282834 |
| 158 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86205187 |
| 159 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86205187 |
| 160 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86089573 |
| 161 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85601437 |
| 162 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85495553 |
| 163 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85424010 |
| 164 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85248848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 6.31676795 |
| 2 | MP0003011_delayed_dark_adaptation | 5.66818289 |
| 3 | MP0003724_increased_susceptibility_to | 4.26282286 |
| 4 | MP0005253_abnormal_eye_physiology | 3.99794285 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 3.81190625 |
| 6 | * MP0002090_abnormal_vision | 3.59389838 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.52009088 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.91895982 |
| 9 | MP0005451_abnormal_body_composition | 2.66012162 |
| 10 | * MP0005195_abnormal_posterior_eye | 2.65723127 |
| 11 | MP0001324_abnormal_eye_pigmentation | 2.61726660 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.54967337 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.35906975 |
| 14 | MP0005025_abnormal_response_to | 2.27565752 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.26243958 |
| 16 | MP0008260_abnormal_autophagy | 2.23368563 |
| 17 | MP0005387_immune_system_phenotype | 2.19732744 |
| 18 | MP0001790_abnormal_immune_system | 2.19732744 |
| 19 | MP0000685_abnormal_immune_system | 2.18461953 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.17205195 |
| 21 | MP0001346_abnormal_lacrimal_gland | 2.13458081 |
| 22 | MP0005391_vision/eye_phenotype | 2.10608529 |
| 23 | MP0009785_altered_susceptibility_to | 2.09942320 |
| 24 | MP0008004_abnormal_stomach_pH | 2.05544360 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.04439954 |
| 26 | MP0001800_abnormal_humoral_immune | 2.04407879 |
| 27 | MP0005257_abnormal_intraocular_pressure | 2.04343502 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.03925185 |
| 29 | MP0005671_abnormal_response_to | 2.00991556 |
| 30 | MP0002723_abnormal_immune_serum | 1.98774525 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.95884464 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.95528929 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.93812089 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.93362126 |
| 35 | MP0001819_abnormal_immune_cell | 1.93052890 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.92285866 |
| 37 | MP0003303_peritoneal_inflammation | 1.89431289 |
| 38 | MP0002405_respiratory_system_inflammati | 1.78354063 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.63072661 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.62516739 |
| 41 | MP0000858_altered_metastatic_potential | 1.61497617 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.60441745 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.59049332 |
| 44 | MP0009840_abnormal_foam_cell | 1.58085327 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.53602555 |
| 46 | MP0005248_abnormal_Harderian_gland | 1.52248980 |
| 47 | * MP0002229_neurodegeneration | 1.51119739 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.50671910 |
| 49 | MP0002132_abnormal_respiratory_system | 1.50244775 |
| 50 | MP0004510_myositis | 1.50185902 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.49243806 |
| 52 | MP0002398_abnormal_bone_marrow | 1.48568910 |
| 53 | MP0003690_abnormal_glial_cell | 1.46551023 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.44980283 |
| 55 | MP0009278_abnormal_bone_marrow | 1.44763097 |
| 56 | MP0000716_abnormal_immune_system | 1.44699172 |
| 57 | MP0004883_abnormal_blood_vessel | 1.43437741 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.39528047 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.39356192 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.38613308 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.38613308 |
| 62 | MP0005197_abnormal_uvea_morphology | 1.34174572 |
| 63 | MP0002254_reproductive_system_inflammat | 1.31759368 |
| 64 | MP0002722_abnormal_immune_system | 1.29792508 |
| 65 | MP0003091_abnormal_cell_migration | 1.29633796 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 1.28259757 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.27891531 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.27873999 |
| 69 | MP0003045_fibrosis | 1.24613615 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.23731383 |
| 71 | MP0004272_abnormal_basement_membrane | 1.23671578 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.23635692 |
| 73 | MP0000733_abnormal_muscle_development | 1.23332095 |
| 74 | MP0008469_abnormal_protein_level | 1.21674330 |
| 75 | MP0002429_abnormal_blood_cell | 1.20793100 |
| 76 | MP0009764_decreased_sensitivity_to | 1.19525637 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.18888569 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.18563618 |
| 79 | MP0003634_abnormal_glial_cell | 1.17789875 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.16558090 |
| 81 | MP0000343_altered_response_to | 1.14503489 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.13143957 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.12679598 |
| 84 | MP0001853_heart_inflammation | 1.12134771 |
| 85 | MP0005310_abnormal_salivary_gland | 1.11916054 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.11715347 |
| 87 | MP0002928_abnormal_bile_duct | 1.11648759 |
| 88 | MP0001958_emphysema | 1.10327962 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.09227455 |
| 90 | MP0003075_altered_response_to | 1.06562353 |
| 91 | MP0005076_abnormal_cell_differentiation | 1.05585174 |
| 92 | MP0004084_abnormal_cardiac_muscle | 1.05228401 |
| 93 | MP0005390_skeleton_phenotype | 1.00846340 |
| 94 | MP0003279_aneurysm | 1.00560950 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.98076307 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.97765137 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.96081694 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.95807069 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.93697609 |
| 100 | MP0003866_abnormal_defecation | 0.92854060 |
| 101 | MP0004043_abnormal_pH_regulation | 0.91191686 |
| 102 | MP0005166_decreased_susceptibility_to | 0.91019437 |
| 103 | MP0003436_decreased_susceptibility_to | 0.90643185 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.89449024 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89067164 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.89020197 |
| 107 | MP0000604_amyloidosis | 0.88816216 |
| 108 | MP0004381_abnormal_hair_follicle | 0.88644337 |
| 109 | MP0003795_abnormal_bone_structure | 0.85613709 |
| 110 | MP0003828_pulmonary_edema | 0.85204290 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.84291381 |
| 112 | MP0003329_amyloid_beta_deposits | 0.84273728 |
| 113 | MP0006082_CNS_inflammation | 0.81725611 |
| 114 | MP0000920_abnormal_myelination | 0.81020053 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.80416557 |
| 116 | MP0005670_abnormal_white_adipose | 0.79036349 |
| 117 | * MP0002752_abnormal_somatic_nervous | 0.78884885 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.78436626 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.77675291 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.77037842 |
| 121 | MP0009763_increased_sensitivity_to | 0.76563794 |
| 122 | MP0008961_abnormal_basal_metabolism | 0.76493749 |
| 123 | MP0006054_spinal_hemorrhage | 0.75937396 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.74908586 |
| 125 | MP0002168_other_aberrant_phenotype | 0.73487577 |
| 126 | MP0003283_abnormal_digestive_organ | 0.72996304 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.72403481 |
| 128 | MP0005023_abnormal_wound_healing | 0.70041438 |
| 129 | MP0008789_abnormal_olfactory_epithelium | 0.69957604 |
| 130 | MP0000249_abnormal_blood_vessel | 0.69527318 |
| 131 | MP0001984_abnormal_olfaction | 0.68636591 |
| 132 | MP0001849_ear_inflammation | 0.68506619 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.68286333 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.67979268 |
| 135 | MP0000490_abnormal_crypts_of | 0.67934656 |
| 136 | MP0004036_abnormal_muscle_relaxation | 0.67693166 |
| 137 | MP0004858_abnormal_nervous_system | 0.67519476 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.67491129 |
| 139 | MP0005499_abnormal_olfactory_system | 0.67491129 |
| 140 | MP0005621_abnormal_cell_physiology | 0.67335720 |
| 141 | MP0003252_abnormal_bile_duct | 0.66824061 |
| 142 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66621622 |
| 143 | MP0001614_abnormal_blood_vessel | 0.66484866 |
| 144 | MP0002234_abnormal_pharynx_morphology | 0.66459194 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.65666811 |
| 146 | MP0001915_intracranial_hemorrhage | 0.65438221 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.64742897 |
| 148 | MP0001756_abnormal_urination | 0.64526326 |
| 149 | MP0003448_altered_tumor_morphology | 0.64484825 |
| 150 | MP0003195_calcinosis | 0.64474567 |
| 151 | MP0005164_abnormal_response_to | 0.63622022 |
| 152 | MP0004130_abnormal_muscle_cell | 0.63467836 |
| 153 | MP0002419_abnormal_innate_immunity | 0.62486541 |
| 154 | MP0002133_abnormal_respiratory_system | 0.61884064 |
| 155 | MP0001851_eye_inflammation | 0.61841966 |
| 156 | MP0000749_muscle_degeneration | 0.61309454 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.61057128 |
| 158 | MP0000767_abnormal_smooth_muscle | 0.60596666 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.60363878 |
| 160 | MP0005193_abnormal_anterior_eye | 0.59912936 |
| 161 | MP0005165_increased_susceptibility_to | 0.59122313 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.58227168 |
| 163 | MP0002925_abnormal_cardiovascular_devel | 0.57365879 |
| 164 | MP0004947_skin_inflammation | 0.57258196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bony spicule pigmentary retinopathy (HP:0007737) | 7.21032167 |
| 2 | Central scotoma (HP:0000603) | 6.92305730 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 6.78819740 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.69409851 |
| 5 | Scotoma (HP:0000575) | 5.59674748 |
| 6 | Pigmentary retinal degeneration (HP:0001146) | 5.54695474 |
| 7 | Dyschromatopsia (HP:0007641) | 5.52634612 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.17190460 |
| 9 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.71332801 |
| 10 | Chorioretinal atrophy (HP:0000533) | 4.64522208 |
| 11 | Decreased central vision (HP:0007663) | 4.56741510 |
| 12 | Attenuation of retinal blood vessels (HP:0007843) | 4.45337731 |
| 13 | Myositis (HP:0100614) | 4.30198471 |
| 14 | Orchitis (HP:0100796) | 4.28267740 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19329683 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 4.09070451 |
| 17 | Severe visual impairment (HP:0001141) | 3.93073709 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.85754491 |
| 19 | Optic neuritis (HP:0100653) | 3.85754491 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.72886143 |
| 21 | Cone-rod dystrophy (HP:0000548) | 3.69014208 |
| 22 | Photophobia (HP:0000613) | 3.49739779 |
| 23 | Choroideremia (HP:0001139) | 3.45583599 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.45247210 |
| 25 | Pendular nystagmus (HP:0012043) | 3.42733847 |
| 26 | Macular degeneration (HP:0000608) | 3.38330285 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.36863897 |
| 28 | Progressive visual loss (HP:0000529) | 3.28602447 |
| 29 | Stomatitis (HP:0010280) | 3.19179262 |
| 30 | Increased corneal curvature (HP:0100692) | 3.16683942 |
| 31 | Keratoconus (HP:0000563) | 3.16683942 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.15674597 |
| 33 | Obstructive lung disease (HP:0006536) | 3.15552280 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15552280 |
| 35 | Recurrent skin infections (HP:0001581) | 3.15532290 |
| 36 | Type II diabetes mellitus (HP:0005978) | 3.14119165 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.10230359 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09761191 |
| 39 | Retinal atrophy (HP:0001105) | 2.94154019 |
| 40 | Cellulitis (HP:0100658) | 2.83829629 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.80324399 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79771150 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.79034330 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.77840999 |
| 45 | Increased IgE level (HP:0003212) | 2.75887196 |
| 46 | Peritonitis (HP:0002586) | 2.68109324 |
| 47 | Meningitis (HP:0001287) | 2.67345158 |
| 48 | Constricted visual fields (HP:0001133) | 2.66239934 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65614184 |
| 50 | Urticaria (HP:0001025) | 2.63331381 |
| 51 | T lymphocytopenia (HP:0005403) | 2.60866651 |
| 52 | Arterial thrombosis (HP:0004420) | 2.58699277 |
| 53 | Posterior subcapsular cataract (HP:0007787) | 2.55158475 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.52620856 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52620856 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51858239 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51858239 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51858239 |
| 59 | Amyloidosis (HP:0011034) | 2.51283936 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.50202893 |
| 61 | Axonal loss (HP:0003447) | 2.49007972 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.48103542 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47459873 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47459873 |
| 65 | Chest pain (HP:0100749) | 2.45394105 |
| 66 | Osteomyelitis (HP:0002754) | 2.41238936 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.40064273 |
| 68 | Vasculitis (HP:0002633) | 2.36735071 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.32738389 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32385663 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.32027786 |
| 72 | Gingival bleeding (HP:0000225) | 2.28578384 |
| 73 | Urethral obstruction (HP:0000796) | 2.28406439 |
| 74 | Retinitis pigmentosa (HP:0000510) | 2.27536637 |
| 75 | Encephalitis (HP:0002383) | 2.26540722 |
| 76 | Subacute progressive viral hepatitis (HP:0006572) | 2.26153999 |
| 77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.23801770 |
| 78 | Epistaxis (HP:0000421) | 2.20509721 |
| 79 | Hemoptysis (HP:0002105) | 2.20492470 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20101437 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20101437 |
| 82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20101437 |
| 83 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19950099 |
| 84 | Episodic fever (HP:0001954) | 2.16497984 |
| 85 | Subcapsular cataract (HP:0000523) | 2.13794989 |
| 86 | Premature rupture of membranes (HP:0001788) | 2.12647103 |
| 87 | Recurrent viral infections (HP:0004429) | 2.12286470 |
| 88 | Thick nail (HP:0001805) | 2.11929504 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.05627283 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 2.04277427 |
| 91 | Polycythemia (HP:0001901) | 2.03952957 |
| 92 | Leukocytosis (HP:0001974) | 2.03045242 |
| 93 | Vitreoretinal degeneration (HP:0000655) | 2.01019063 |
| 94 | Congenital stationary night blindness (HP:0007642) | 11.9652920 |
| 95 | Premature loss of primary teeth (HP:0006323) | 1.99884575 |
| 96 | Anorexia (HP:0002039) | 1.99344947 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.99259714 |
| 98 | Hepatosplenomegaly (HP:0001433) | 1.98447567 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98430201 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 1.98069152 |
| 101 | Abnormal platelet volume (HP:0011876) | 1.96310639 |
| 102 | Pulmonary embolism (HP:0002204) | 1.95650219 |
| 103 | Arterial tortuosity (HP:0005116) | 1.92491787 |
| 104 | Colitis (HP:0002583) | 1.88066876 |
| 105 | Acne (HP:0001061) | 1.87986279 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 1.85236653 |
| 107 | Abnormality of the endocardium (HP:0004306) | 1.84312776 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 1.83797406 |
| 109 | Pustule (HP:0200039) | 1.83158920 |
| 110 | Glomerulopathy (HP:0100820) | 1.83074409 |
| 111 | Increased serum ferritin (HP:0003281) | 1.82518516 |
| 112 | Loss of speech (HP:0002371) | 1.82160925 |
| 113 | Cerebral aneurysm (HP:0004944) | 1.81513000 |
| 114 | Mutism (HP:0002300) | 1.81111692 |
| 115 | Petechiae (HP:0000967) | 1.81035922 |
| 116 | Viral hepatitis (HP:0006562) | 1.79150124 |
| 117 | Metaphyseal cupping (HP:0003021) | 1.78966276 |
| 118 | Abnormality of macrophages (HP:0004311) | 1.78228212 |
| 119 | Neurofibrillary tangles (HP:0002185) | 1.76829115 |
| 120 | Vascular tortuosity (HP:0004948) | 1.76467853 |
| 121 | Myocardial infarction (HP:0001658) | 1.76455419 |
| 122 | Sepsis (HP:0100806) | 1.75056046 |
| 123 | Purpura (HP:0000979) | 1.74663413 |
| 124 | Supranuclear gaze palsy (HP:0000605) | 1.73633102 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.72281878 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 1.71330166 |
| 127 | Upper limb amyotrophy (HP:0009129) | 1.71330166 |
| 128 | Amaurosis fugax (HP:0100576) | 1.70568202 |
| 129 | Absent frontal sinuses (HP:0002688) | 1.70071824 |
| 130 | Eczematoid dermatitis (HP:0000976) | 1.69060076 |
| 131 | Granulocytopenia (HP:0001913) | 1.68685159 |
| 132 | Fatigue (HP:0012378) | 1.68487375 |
| 133 | Increased connective tissue (HP:0009025) | 1.66755966 |
| 134 | Esophageal varix (HP:0002040) | 1.66628665 |
| 135 | Spinal cord lesions (HP:0100561) | 1.65153970 |
| 136 | Syringomyelia (HP:0003396) | 1.65153970 |
| 137 | Skin ulcer (HP:0200042) | 1.64615562 |
| 138 | Autoimmune thrombocytopenia (HP:0001973) | 1.64162648 |
| 139 | Increased circulating renin level (HP:0000848) | 1.63576421 |
| 140 | Abnormality of the fingertips (HP:0001211) | 1.62554453 |
| 141 | Gangrene (HP:0100758) | 1.62178653 |
| 142 | Albinism (HP:0001022) | 1.60215908 |
| 143 | Severe Myopia (HP:0011003) | 1.57576403 |
| 144 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.56365360 |
| 145 | Hypoplasia of the fovea (HP:0007750) | 1.56365360 |
| 146 | Spondylolisthesis (HP:0003302) | 1.56342140 |
| 147 | Lower limb amyotrophy (HP:0007210) | 1.55430355 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.54863246 |
| 149 | Osteolytic defects of the hand bones (HP:0009699) | 1.54863246 |
| 150 | Systemic lupus erythematosus (HP:0002725) | 1.51243599 |
| 151 | Broad metatarsal (HP:0001783) | 1.48653476 |
| 152 | Submucous cleft hard palate (HP:0000176) | 1.47596577 |
| 153 | Atrophic scars (HP:0001075) | 1.46872768 |
| 154 | Aortic dissection (HP:0002647) | 1.44017143 |
| 155 | Hematochezia (HP:0002573) | 1.43961139 |
| 156 | Aortic aneurysm (HP:0004942) | 1.43189531 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.41410646 |
| 158 | Prolonged QT interval (HP:0001657) | 1.39642097 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.39327489 |
| 160 | Scapular winging (HP:0003691) | 1.38829120 |
| 161 | Disinhibition (HP:0000734) | 1.38340129 |
| 162 | Shallow orbits (HP:0000586) | 1.37700029 |
| 163 | Recurrent abscess formation (HP:0002722) | 1.37138290 |
| 164 | Increased CSF protein (HP:0002922) | 1.36783288 |
| 165 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.36242460 |
| 166 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.36078262 |
| 167 | Gingivitis (HP:0000230) | 1.35656952 |
| 168 | Abnormality of the fovea (HP:0000493) | 1.34913741 |
| 169 | Exercise-induced muscle cramps (HP:0003710) | 1.34909534 |
| 170 | Genetic anticipation (HP:0003743) | 1.34643271 |
| 171 | Macroorchidism (HP:0000053) | 1.34637908 |
| 172 | Polar cataract (HP:0010696) | 1.34637308 |
| 173 | Coarse hair (HP:0002208) | 1.34245068 |
| 174 | Focal segmental glomerulosclerosis (HP:0000097) | 1.33528095 |
| 175 | Septo-optic dysplasia (HP:0100842) | 1.32446671 |
| 176 | Hyperactive renin-angiotensin system (HP:0000841) | 1.29251787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.29711744 |
| 2 | PBK | 3.61996018 |
| 3 | GRK1 | 3.46303920 |
| 4 | BLK | 2.79003135 |
| 5 | IRAK4 | 2.65108380 |
| 6 | MAP2K3 | 2.63120067 |
| 7 | INSRR | 2.54175075 |
| 8 | RIPK1 | 2.28978497 |
| 9 | TTN | 2.27565849 |
| 10 | EPHB1 | 2.23058348 |
| 11 | MAP4K1 | 2.09313411 |
| 12 | CAMK1D | 2.05377612 |
| 13 | KSR2 | 2.01568935 |
| 14 | CAMK1G | 1.98918239 |
| 15 | ERN1 | 1.97253810 |
| 16 | ZAP70 | 1.91414145 |
| 17 | IRAK3 | 1.83853200 |
| 18 | JAK3 | 1.71453831 |
| 19 | TAOK3 | 1.67577965 |
| 20 | CDK12 | 1.62654853 |
| 21 | LATS1 | 1.56700145 |
| 22 | PAK6 | 1.51803235 |
| 23 | TAOK2 | 1.50035520 |
| 24 | SMG1 | 1.49642798 |
| 25 | EPHA3 | 1.48828316 |
| 26 | MAP3K1 | 1.47809114 |
| 27 | HIPK2 | 1.47558874 |
| 28 | TGFBR2 | 1.45463307 |
| 29 | TAOK1 | 1.40946501 |
| 30 | JAK2 | 1.39019911 |
| 31 | DMPK | 1.34095799 |
| 32 | YES1 | 1.32209023 |
| 33 | PTK2 | 1.31893915 |
| 34 | PTK6 | 1.31263200 |
| 35 | BRD4 | 1.30737716 |
| 36 | BTK | 1.26023061 |
| 37 | NUAK1 | 1.25665166 |
| 38 | GRK6 | 1.25195924 |
| 39 | IRAK1 | 1.21240036 |
| 40 | WNK1 | 1.15670174 |
| 41 | SIK2 | 1.12915813 |
| 42 | CDC42BPA | 1.11823321 |
| 43 | MATK | 1.11351159 |
| 44 | PAK3 | 1.10374450 |
| 45 | BMX | 1.10063099 |
| 46 | WNK4 | 1.06685046 |
| 47 | STK10 | 1.05232065 |
| 48 | FER | 1.05134296 |
| 49 | IKBKE | 1.04570539 |
| 50 | TRIB3 | 1.04249417 |
| 51 | STK38 | 1.03887770 |
| 52 | MAP3K6 | 1.02789204 |
| 53 | TIE1 | 1.01276063 |
| 54 | DYRK1B | 1.00126224 |
| 55 | MARK2 | 0.99862539 |
| 56 | MAPK15 | 0.99720896 |
| 57 | SIK1 | 0.98042213 |
| 58 | SYK | 0.98015513 |
| 59 | TYK2 | 0.97876799 |
| 60 | MAP3K14 | 0.97457778 |
| 61 | FGFR3 | 0.97020352 |
| 62 | MAP3K3 | 0.91675519 |
| 63 | MAP3K13 | 0.91188954 |
| 64 | SIK3 | 0.90887272 |
| 65 | BMPR2 | 0.90679038 |
| 66 | PRPF4B | 0.89081454 |
| 67 | TRPM7 | 0.88726408 |
| 68 | MET | 0.87418392 |
| 69 | JAK1 | 0.87242483 |
| 70 | PDGFRA | 0.86804495 |
| 71 | LYN | 0.86651301 |
| 72 | PDPK1 | 0.86463597 |
| 73 | DDR2 | 0.86441100 |
| 74 | KDR | 0.84435176 |
| 75 | MAP3K11 | 0.83865434 |
| 76 | TNK2 | 0.83745564 |
| 77 | CAMK2D | 0.83594291 |
| 78 | MAPK7 | 0.83105478 |
| 79 | KSR1 | 0.82332704 |
| 80 | CDK6 | 0.82103480 |
| 81 | MTOR | 0.81760168 |
| 82 | PRKAA2 | 0.80424120 |
| 83 | PRKCH | 0.79571835 |
| 84 | PAK4 | 0.79557181 |
| 85 | PDGFRB | 0.79393511 |
| 86 | MAP3K2 | 0.79251257 |
| 87 | PDK1 | 0.78728827 |
| 88 | PAK2 | 0.78544583 |
| 89 | CSF1R | 0.78183768 |
| 90 | STK39 | 0.77808869 |
| 91 | PRKD1 | 0.76802066 |
| 92 | LCK | 0.76326724 |
| 93 | EPHB2 | 0.74775026 |
| 94 | MAP3K7 | 0.74525039 |
| 95 | KIT | 0.73870822 |
| 96 | TXK | 0.73813008 |
| 97 | CSK | 0.73342070 |
| 98 | RAF1 | 0.72672161 |
| 99 | FRK | 0.72310685 |
| 100 | MARK3 | 0.72225172 |
| 101 | FES | 0.71688210 |
| 102 | MOS | 0.69825747 |
| 103 | LRRK2 | 0.69160362 |
| 104 | PTK2B | 0.68825495 |
| 105 | ICK | 0.68296814 |
| 106 | MAP3K8 | 0.66509006 |
| 107 | GSK3A | 0.65478527 |
| 108 | TBK1 | 0.64680057 |
| 109 | NTRK1 | 0.64586405 |
| 110 | OXSR1 | 0.64585015 |
| 111 | PRKCE | 0.64362077 |
| 112 | RPS6KA4 | 0.63687342 |
| 113 | FGR | 0.63498442 |
| 114 | EEF2K | 0.62849398 |
| 115 | ITK | 0.62644853 |
| 116 | RET | 0.62036731 |
| 117 | PRKG2 | 0.60845070 |
| 118 | MAP2K2 | 0.60303051 |
| 119 | CDK9 | 0.59227829 |
| 120 | INSR | 0.58951460 |
| 121 | RPS6KL1 | 0.58515270 |
| 122 | RPS6KC1 | 0.58515270 |
| 123 | PKN2 | 0.57720170 |
| 124 | ERBB2 | 0.56666869 |
| 125 | HCK | 0.56342681 |
| 126 | SRC | 0.56193517 |
| 127 | FYN | 0.56039173 |
| 128 | IRAK2 | 0.55777893 |
| 129 | EGFR | 0.55173819 |
| 130 | MAP3K5 | 0.55032703 |
| 131 | CLK1 | 0.54802956 |
| 132 | ABL1 | 0.54041941 |
| 133 | STK3 | 0.53443075 |
| 134 | IKBKB | 0.53433915 |
| 135 | FGFR4 | 0.53193488 |
| 136 | PIK3CG | 0.52638150 |
| 137 | SGK3 | 0.52529358 |
| 138 | PKN1 | 0.52368654 |
| 139 | CAMKK1 | 0.51550255 |
| 140 | MAPK12 | 0.50649719 |
| 141 | CSNK1D | 0.50629127 |
| 142 | CHUK | 0.50558400 |
| 143 | ALK | 0.49165967 |
| 144 | NEK9 | 0.49036754 |
| 145 | RPS6KA2 | 0.48602378 |
| 146 | SGK223 | 0.47994370 |
| 147 | SGK494 | 0.47994370 |
| 148 | PRKAA1 | 0.47604824 |
| 149 | NLK | 0.47056150 |
| 150 | PRKD2 | 0.47019615 |
| 151 | MAP3K10 | 0.46733181 |
| 152 | GRK7 | 0.44145199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 7.82044780 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10019179 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00762116 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.91968639 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.88196739 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74574675 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68514339 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66056940 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56867858 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55388657 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53879406 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.46696968 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.45792614 |
| 14 | Mineral absorption_Homo sapiens_hsa04978 | 1.43862547 |
| 15 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43828613 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.40867665 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37059927 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37051870 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.36664064 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33973704 |
| 21 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32462805 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29977463 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27955012 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.27087029 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.27035195 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25903438 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24121259 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.22123909 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20661144 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19036610 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.18853228 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18182720 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16740995 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16495325 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.16477024 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.09606970 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09391635 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08007912 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07993326 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.05170079 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04176845 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04175816 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.03436330 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03337498 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02718810 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02483290 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01529077 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01324512 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01252546 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00340136 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99707555 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.97438151 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.95472778 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95229410 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94453301 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.93724254 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91119064 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.90088953 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88862733 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88470042 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88462055 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88018853 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87906069 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87894297 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87662725 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.86446972 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.86283344 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84996851 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83839267 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.83594323 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81863830 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79457694 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78370279 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.78144663 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77774090 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.77040110 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77021695 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76284881 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.75805057 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75788307 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75345288 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75264084 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72362649 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71870152 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70275509 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70187107 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70006776 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.69590309 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69053794 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68842317 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68793186 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68514479 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67595194 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67074848 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66980723 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66365822 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66323911 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66027661 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65170625 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65099363 |
| 101 | Tuberculosis_Homo sapiens_hsa05152 | 0.63890841 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.63175627 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62873805 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62522976 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.62144900 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62063201 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61375757 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61142385 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.61127084 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60788636 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.60618932 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60553465 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60531794 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58244667 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58237313 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.56966607 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56524079 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54143978 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53900173 |
| 120 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53760857 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53634824 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.53588197 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53391007 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53364954 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53181554 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52924818 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52478111 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51744826 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50669189 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49555576 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49259779 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.48925386 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48426434 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48329971 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47935440 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47908612 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47247350 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.47072510 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46572855 |
| 140 | Salmonella infection_Homo sapiens_hsa05132 | 0.46121581 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45907078 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45751241 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45573276 |
| 144 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45334859 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.45241078 |
| 146 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44569836 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44105218 |
| 148 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43289190 |
| 149 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43239416 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43102271 |

